Most Viewed Leukemia Current Events | Leukemia News
|
| Page
1 of
10 |
196 Results |
|
|
|
Sort By:
Relevance | Date |
Steroids and chicken pox not a good mix
Children who have been treated with steroids and are exposed to chicken pox tend to have a more severe case of the virus. view more (2005-10-19)
Retinol for combating leukemia cells
Vitamin A, also known as retinol, is present in milk, liver, egg yolk, butter and other foodstuffs and as carotene in vegetables that have a yellow-orange colour, such as carrots and pumpkins. view more (2006-01-09)
New studies identify advances in treatment of chronic myeloid leukemia
Offering promise in the battle against cancer, the results from five studies highlighting new advances in the treatment of chronic myeloid leukemia (CML) - a slow-progressing, malignant bone marrow cancer - will be presented at the 47th Annual Meeting of the American Society of Hematology. view more (2005-12-12)
National study improves outcome for pediatric AML
A new strategy for treating childhood acute myeloid leukemia (AML) based on the individual patient's risk of failure, and guided by the results of a highly sensitive technique for identifying leukemic cells, yielded one-year survival rates of almost 90 percent. view more (2005-12-14)
Tulane pioneers novel ovarian cancer treatment
The Tulane University Section of Hematology and Medical Oncology is investigating a novel treatment for ovarian cancer by using intravenous Ontak to deplete harmful cells that inhibit the body's natural immune response to fight cancer. Ovarian cancer is the fifth leading cancer killer of women in the United States. view more (2005-07-18)
Discovery in 'Bubble Boy' disease gene therapy
Scientists at St. Jude Children's Research Hospital have developed a mouse model of a severe disease of the immune system that helps explain why gene therapy used to treat children with this disease at an institution in Europe caused some of them to develop leukemia. view more (2006-08-02)
New treatment for specific type of leukemia
Leukemia - or cancer of the bone marrow - strikes some 700 Belgians each year. Chronic Eosinophilic Leukemia (CEL), a specific form of leukemia, is currently treated with Glivec. However, recent research has shown that prolonged usage can cause resistance to Glivec, rendering this chronic form of leukemia untreatable. view more (2006-05-10)
U of M researchers discover compounds to shrink tumors
Researchers at the University of Minnesota have developed novel anti-cancer drugs to treat solid tumors. These "small molecules" belong to a class of pharmaceutical agents called anti-angiogenics. view more (2006-07-06)
New treatment option breaks Leukemia's resistance to chemotherapy, radiation therapy
German researchers set out to outwit cancer tumor cells that have become resistant to chemotherapy or radiation therapy and ended up expanding therapeutic applications of radionuclides in fighting leukemia. view more (2006-06-05)
Dartmouth researchers find that arsenic triggers unique mechanism in rare leukemia
Dartmouth Medical School (DMS) researchers have identified a new way that arsenite, a form of arsenic, acts in treating a rare cancer known as APL, or acute promyelocytic leukemia. Their study is published in the Jan. 3 issue of the Journal of the National Cancer Institute. view more (2007-01-09)
Mutation in blood stem cells provides clues to cancer development
The discovery suggests that development of a very specific inhibitor at the stem-cell level, to interfere with the pathway leading to the disease, could improve treatment for the cancer-causing disorder. view more (2006-04-07)
Silencing a protein could kill T-Cells, reverse leukemia
Blocking the signals from a protein that activates cells in the immune system could help kill cells that cause a rare form of blood cancer, according to physicists and oncologists who combined computer modeling and molecular biology in their discovery. view more (2008-10-23)
MiRNA Fingerprint Identified in Platelet Formation
Scientists have identified a handful of microRNAs (miRNAs) that appear to play a significant role in the development of platelets - blood cells critical to the body's ability to form clots following an injury. view more (2006-03-17)
Cincinnati Children's researchers publish findings on potential target for leukemia treatment
Cincinnati Children's Hospital Medical Center today announced the publication of pioneering research identifying the crucial role and novel mechanism of action of the protein RhoH GTPase in the development and activation of cells critical to the immune system. view more (2006-10-10)
Retinoblastoma researchers find success with two-drug combination
Retinoblastoma is a tumor that arises in the cells of the retina, the light-sensitive tissue at the back of the eyeball, following mutation of the gene RB1. view more (2005-10-18)
Mouse study reveals human X-SCID gene therapy poses substantial cancer risk
New animal studies conducted at the Salk Institute for Biological Studies show that the only human gene therapy treatment to date considered to be largely successful, is, in fact, riskier than realized. view more (2006-04-27)
Drug that battles resistance to leukemia pill Gleevec 'extremely effective' against cancer
An experimental therapy that battles drug resistance in Chronic Myeloid Leukemia (CML) has proved "extremely effective" in fighting cancer, giving patients for whom all conventional therapies have failed another option. view more (2006-06-15)
St. Jude unlocks mystery of very aggressive leukemia
Investigators at St. Jude Children's Research Hospital have used mouse models to determine why some forms of acute lymphoblastic leukemia (ALL) are extremely aggressive and resist a drug that is effective in treating a different type of leukemia. view more (2006-04-20)
Leukemia gene normally has mammary gland function
A gene that is critical for normal mammary gland function during nursing helps trigger a highly lethal group of leukemias when it undergoes a mutation that fuses it to another gene view more (2006-07-20)
AMN107 has potent activity in leukemia resistant to Gleevec
The targeted agent AMN107 can produce dramatic benefits in patients with some forms of leukemia that are resistant to Gleevec, the standard therapy for these cancers, say researchers at The University of Texas M. D. Anderson Cancer Center. view more (2005-12-12)
|
|
| Page
1 of
10 |
196 Results |
|
|
|
Sort By:
Relevance | Date |
|
